Cargando…
Ubiquitin-specific protease 2 decreases p53-dependent apoptosis in cutaneous T-cell lymphoma
Treatment of advanced cutaneous T-cell lymphomas (CTCL) is challenging because they are resistant to conventional chemotherapy. USP2 has been shown to promote resistance to chemotherapeutic agents in several cancer models. We show here USP2 is expressed in quiescent and activated T-cells and its exp...
Autores principales: | Wei, Tianling, Biskup, Edyta, Rahbek Gjerdrum, Lise Mette, Niazi, Omid, Ødum, Niels, Gniadecki, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217025/ https://www.ncbi.nlm.nih.gov/pubmed/27351221 http://dx.doi.org/10.18632/oncotarget.10268 |
Ejemplares similares
-
miR-122 Regulates p53/Akt Signalling and the Chemotherapy-Induced Apoptosis in Cutaneous T-Cell Lymphoma
por: Manfè, Valentina, et al.
Publicado: (2012) -
TP53 Gene Status Affects Survival in Advanced Mycosis Fungoides
por: Wooler, Gitte, et al.
Publicado: (2016) -
Growth dynamics and cyclin expression in cutaneous T-cell lymphoma cell lines
por: Biskup, Edyta, et al.
Publicado: (2010) -
cMyc/miR-125b-5p Signalling Determines Sensitivity to Bortezomib in Preclinical Model of Cutaneous T-Cell Lymphomas
por: Manfè, Valentina, et al.
Publicado: (2013) -
MicroRNAs in the Pathogenesis, Diagnosis, Prognosis and Targeted Treatment of Cutaneous T-Cell Lymphomas
por: Gluud, Maria, et al.
Publicado: (2020)